Higher preference for economically profitable development of food and drug products will strengthen global cyclodextrin (CD) market forecast. Cyclodextrin is apt at improving the bioavailability of drug molecules, rendering it an excellent ingredient in the production of a host of cosmetic, personal care, pharmaceutical, and food & beverage products.
Roquette Frères, Merck KGaA, Wacker Chemie AG, Central Drug House, Shandong Xinda Biotechnology Co., Ltd., Zhonglan Industry Co., Ltd., Ottokemi, and Cyclolab are a few top cyclodextrin manufacturers in the global landscape.
Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/5116
By 2027, the global cyclodextrin market size is expected to be more than $390 million, thanks to the surging funding activities supporting R&D initiatives across drug companies. Introduction of new-age supplements and nutraceuticals has been accelerating product use across European countries including Germany and U.K.
- Spiraling demand for anti-aging beauty formulations in Asia Pacific
Since the onset of the COVID-19 pandemic, individuals across the globe have been refocusing their interest on physical well-being and personal appearance. Facial aesthetics have become a key determinant of a person’s self-esteem and mental health, especially over the past few years. Growing preference for a base make-up amongst millennials will fuel Asia Pacific cyclodextrin industry share.
Customers in Asia Pacific have been investing in premium quality face serums, creams, and body lotions. Since the product offers exceptional solubility, stability, and safety, it is being used by top cosmetic brands in the composition of cosmetic and beauty products.
- Pharma companies focus on expanding product pipeline
U.S. gamma cyclodextrin industry size is expected to rise at a notable pace by 2027, owing to the escalating competition amongst regional pharma companies to produce effective drugs and treatments. As cyclodextrin-based drugs can be instrumental in the treatment of early Alzheimer’s disease, drug developers are tapping product potential and expanding their pipeline.
In March 2022, U.S.-based drug manufacturer Cyclo Therapeutics, Inc. announced that it has entered a partnership with the University of Witwatersrand in Johannesburg to further develop and coordinate research activities for its proprietary product addressing needs of patients with Alzheimer’s. Trappsol Cyclo helps transportation of cholesterol in patients. It is a formulation containing hydroxypropyl beta cyclodextrin. Increasing prevalence of rare conditions such as Niemann-Pick disease is likely to augment product demand over the next five years.
Request for Report Customization: https://www.gminsights.com/roc/5116
- Rising consumption of packaged food products
Since cyclodextrin is an important ingredient in food science, several food & beverage manufacturers have been consuming it to a greater degree since the pandemic struck across the globe. With individuals returning to their daily routines, the preference for packaged and convenience food is rising. Long office hours and hectic schedules have been encouraging families with kids to opt for these food alternatives.
North America beta cyclodextrin industry share will exhibit a promising growth rate over the next few years, on account of its ability to improve the organoleptic quality of food products, whereby undesirable odors and flavors in food products can be eliminated. Extended shelf life and easy standardization of homogenous compositions are some other major advantages offered by product properties.
Request For TOC of Report @ https://www.gminsights.com/toc/detail/global-cyclodextrin-market
Current research has been exploring the product potential in areas such as smart packaging, nanoparticles, extraction enhancers, and nanosensors. Since their use as complexes formers and carriers that stabilize and protect bioactive compounds has been growing, product adoption for enhancing the overall quality of the final product has been increasing.
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
Corporate Sales, USA
Global Market Insights, Inc.
Toll Free: 1-888-689-0688
Email: [email protected]
Browse More Reports: